Results 151 to 160 of about 24,635 (230)

Lipids mediate podocyte damage [PDF]

Nature Reviews Nephrology, 2019
openaire   +2 more sources

Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice. [PDF]

Int J Mol Sci
Jamaly S, Rakaee M, Ichinose K, Maeda K, Otomo K, Koga T, Tsokos MG, Tsokos GC.   +7 more
europepmc   +1 more source

Podocyte-Derived Extracellular Vesicles Induce Endothelial Dysfunction by Triggering ER Stress in Glomerular Disease. [PDF]

J Extracell Vesicles
Liu Z, Liu X, Wen X, Yan S, He M, Xu J, Zhan Z, Zhu H, Tan H, Jia N, Liu Y.   +10 more
europepmc   +1 more source

Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy. [PDF]

Front Bioeng Biotechnol
Ke J, Cao L, Zhang S, Xing J.
europepmc   +1 more source

CXCL12 limits podocyte regeneration [PDF]

Nature Reviews Nephrology, 2018
openaire   +2 more sources

Making a portal for podocyte-parietal cell communication in glomerular injury. [PDF]

Am J Physiol Renal Physiol
Bruggeman LA.
europepmc   +1 more source

Hirsutine mitigates high glucose-induced cell injury <i>via</i> autophagy activation and NRF2/GPX4-mediated ferroptosis inhibition. [PDF]

Ren Fail
Ni B, Yang Y, Yu B, Tian W, Shi L, Ni Q, Ni J.   +6 more
europepmc   +1 more source

Molecular Mechanisms of APOL1-Associated Kidney Disease. [PDF]

Int J Mol Sci
Delrue C, Speeckaert R, Speeckaert MM.
europepmc   +1 more source

Assessment of Podocyte Function

Kidney and Blood Pressure Research, 1997
openaire   +2 more sources

Unveiling the TrkA-p35/CDK5 axis: a novel therapeutic target in diabetic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Xia W, Wang M, Gao Y, Liu Y, Li J, Zhang H, Luo H, Shen D, E J, Li B, Zheng Y.   +10 more
europepmc   +1 more source